All HHS Contracts — October 15, 2026

Peraton's firm-fixed-price CMS order has $58,992,766 obligated against a $100,701,677 base-plus-options ceiling, with only $34,824,263 outlayed to date. Option exercise would be the main realized-revenue catalyst, though the parent (Veritas Capital) ownership is not publicly traded per the data.

Subawards totaling $47,173,091 across 4 subawards represent roughly 80% of Peraton's $58,992,766 obligation, reducing the prime's retained margin on this work.

Index Analytics' CMS Part B drug technical support delivery order is 76% outlayed ($10,378,814 of $13,603,128), indicating active execution and continued federal demand for this function through a current end date of 2027-04-04.

CORBALT's $10,236,868 CMS delivery order to recompete the Medicaid/CHIP DevSecOps work reaches its stated end date of 2025-08-28 with no remaining option value, so continuity depends on the recompete outcome.

Digital Management's HRSA BPA call obligates $9,261,825 against a $10,459,905 ceiling, implying roughly $1.2M of unexercised option value over the 2026-09-24 to 2027-09-23 period.

RTI's $21,628,322 Time-and-Materials CMS ACO analysis order reports $0 outlayed against its 2026-09-01 start, so realized execution is unverified and the entity is a nonprofit without a public parent.

DPR Construction's $22,341,175 NIH firm-fixed-price construction order lists a 2020-09-01 end date but reports $0 outlayed, so completion and final payments cannot be verified from the data.

AFFIGENT's firm-fixed-price HHS OMAS order for SaaS platform support carries $9,672,378 across a 12-month period from 2026-09-26, with no set-aside and no unexercised option value indicated.

Peraton's $58,992,766 CMS order is the single largest award (about 40% of the $145.7M aggregate), and its subaward pass-through means the prime retains a small share of that value.

Several awards show $0 outlays (DPR Construction past its 2020 end date, RTI, Digital Management, AFFIGENT), leaving realized performance unverified.

CORBALT's MACFC recompete faces a fixed 2025-08-28 end date, and the outcome determines continuity of Medicaid/CHIP DevSecOps services.

Most recipients lack a disclosed public parent or listed equity, so the contract signals cannot be mapped to tradable securities with confidence.

Peraton's CMS Medicare enrollment infrastructure order could expand if options are exercised toward the $100,701,677 ceiling, given its stated sustainment and CI/CD focus.

Index Analytics' 8(a) and small-disadvantaged-business status on the CMS Part B drug support order positions it for follow-on work under small business set-asides.

Digital Management's HRSA BPA call has roughly $1.2M of unexercised option value, providing incremental upside on the recurring Electronic Handbooks and performance-reporting scope.

Across the seven awards, CMS dominates with Peraton, Index Analytics, CORBALT, RTI and AFFIGENT/HHS OMAS tied to Medicare, Medicaid/CHIP and program administration, indicating sustained civilian IT demand. The data does not show multi-year budget direction, so this is continuity rather than confirmed growth.

Index Analytics (8(a) and self-certified small disadvantaged) and CORBALT (total small business set-aside) show policy-driven small business participation in HHS IT work, while Peraton, DPR and Digital Management were full-and-open with no set-aside.

{"entity" => "Peraton Inc. / Veritas Capital", "reason" => "Largest award at $58,992,766 against a $100,701,677 ceiling, with 80% subaward pass-through and $34,824,263 outlayed.", "trigger" => "Option exercise decisions and outlay progression under the CMS order from 2027-10-31 onward"}

{"entity" => "CORBALT, LLC", "reason" => "MACFC recompete of $10,236,868 reaches its 2025-08-28 end date with no remaining option value.", "trigger" => "Recompete award announcement ahead of 2025-08-28"}

{"entity" => "Index Analytics LLC", "reason" => "76% outlayed on a $13,603,128 CMS Part B order with a current end of 2027-04-04.", "trigger" => "Option exercise and potential extension to 2028-04-04"}

{"entity" => "Research Triangle Institute", "reason" => "$21,628,322 CMS ACO order shows $0 outlayed at start of 2026-09-01 performance.", "trigger" => "First outlay reporting after 2026-09-01 and any modification"}